Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 550 of 2228 entries
View as:

A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02254538 Org: User:
Start: 05/31/02 End: - Due: -

Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract in Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT02191189 Org: User:
Start: 05/31/05 End: - Due: -

This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated.

Phase: N/A Priority: Normal
NCT ID: NCT03588390 Org: User:
Start: 07/31/18 End: 11/14/18 Due: 11/14/19

A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.

Phase: N/A Priority: Normal
NCT ID: NCT01703845 Org: User:
Start: 10/31/12 End: 03/31/13 Due: 03/31/14

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04716894 Org: User:
Start: 02/01/21 End: 04/01/21 Due: 04/01/22

An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

Phase: N/A Priority: Normal
NCT ID: NCT00618774 Org: User:
Start: 01/31/08 End: - Due: -

STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT00623623 Org: User:
Start: 03/01/08 End: 09/01/12 Due: 09/01/13

A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00144326 Org: User:
Start: 07/31/03 End: 10/31/05 Due: 10/31/06

Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00904371 Org: User:
Start: 12/31/09 End: - Due: -

Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01734902 Org: User:
Start: 11/01/12 End: 12/01/12 Due: 12/01/13

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT03156114 Org: User:
Start: 06/13/17 End: 06/06/23 Due: 06/06/24

A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01152437 Org: User:
Start: 06/30/10 End: - Due: -

Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183584 Org: User:
Start: 09/30/09 End: - Due: -

Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT00818753 Org: User:
Start: 01/31/09 End: - Due: -

Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02243553 Org: User:
Start: 01/31/06 End: - Due: -

Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece

Phase: N/A Priority: Normal
NCT ID: NCT04672941 Org: User:
Start: 02/16/21 End: 02/21/22 Due: 02/21/23

Tiotropium / Respimat One-Year Study

Phase: N/A Priority: Normal
NCT ID: NCT00168831 Org: User:
Start: 02/28/03 End: - Due: -

Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01491178 Org: User:
Start: 12/12/11 End: 08/02/16 Due: 08/02/17

Pharmacokinetics and Safety of BI 695501 Administered Via Prefilled Syringe or Autoinjector

Phase: N/A Priority: Normal
NCT ID: NCT02606903 Org: User:
Start: 10/28/15 End: 10/04/16 Due: 10/04/17

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Phase: N/A Priority: Normal
NCT ID: NCT00274638 Org: User:
Start: 07/31/02 End: - Due: -

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06528093 Org: User:
Start: 10/16/24 End: 11/24/27 Due: 11/24/28

A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

Phase: N/A Priority: Normal
NCT ID: NCT06077864 Org: User:
Start: 11/20/23 End: 07/13/26 Due: 07/13/27

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06132113 Org: User:
Start: 01/22/24 End: 08/10/26 Due: 08/10/27

Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis

Phase: N/A Priority: Normal
NCT ID: NCT00144274 Org: User:
Start: 04/30/05 End: 11/30/05 Due: 11/30/06

Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02242383 Org: User:
Start: 01/31/05 End: - Due: -